Radioligand Therapy (RLT) Market: Emerging Opportunities, Key Trends, and Competitive Landscape
The Radioligand Therapy (RLT) Market is gaining significant attention because of the growing use of targeted therapies in prostate cancer and other malignancies. The market was valued at USD 8.14 billion in 2024 and is expected to reach USD 21.89 billion by 2035, growing at a CAGR of 9.41% during 2025–2035. Prostate cancer remains the largest indication for radioligand therapy. The strong...
0 Yorumlar 0 hisse senetleri 2 Views 0 önizleme
Comunidad EDUCA https://comunidadeduca.com